These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34146247)

  • 1. Part 2: When Should Bisphosphonates Be Used in Children with Chronic Illness Osteoporosis?
    Ward LM
    Curr Osteoporos Rep; 2021 Jun; 19(3):289-297. PubMed ID: 34146247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?
    Ward LM
    Curr Osteoporos Rep; 2021 Jun; 19(3):278-288. PubMed ID: 34245406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.
    Grover M; Bachrach LK
    Curr Osteoporos Rep; 2017 Aug; 15(4):271-282. PubMed ID: 28620868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.
    Ward LM
    Front Endocrinol (Lausanne); 2020; 11():576. PubMed ID: 33391179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis.
    Cairoli E; Eller-Vainicher C; Ulivieri FM; Zhukouskaya VV; Palmieri S; Morelli V; Beck-Peccoz P; Chiodini I
    Osteoporos Int; 2014 Apr; 25(4):1401-10. PubMed ID: 24510095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.
    Fleurence RL; Iglesias CP; Johnson JM
    Pharmacoeconomics; 2007; 25(11):913-33. PubMed ID: 17960951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
    Ward L; Tricco AC; Phuong P; Cranney A; Barrowman N; Gaboury I; Rauch F; Tugwell P; Moher D
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005324. PubMed ID: 17943849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone protective agents in children.
    Wood CL; Ahmed SF
    Arch Dis Child; 2018 May; 103(5):503-508. PubMed ID: 29066521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Saito T; Sterbenz JM; Malay S; Zhong L; MacEachern MP; Chung KC
    Osteoporos Int; 2017 Dec; 28(12):3289-3300. PubMed ID: 28770272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis in children and adolescents: how to treat and monitor?
    Ciancia S; Högler W; Sakkers RJB; Appelman-Dijkstra NM; Boot AM; Sas TCJ; Renes JS
    Eur J Pediatr; 2023 Feb; 182(2):501-511. PubMed ID: 36472650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENDOCRINOLOGY AND ADOLESCENCE: Osteoporosis in children: diagnosis and management.
    Saraff V; Högler W
    Eur J Endocrinol; 2015 Dec; 173(6):R185-97. PubMed ID: 26041077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review.
    Nasomyont N; Hornung LN; Gordon CM; Wasserman H
    Bone; 2019 Apr; 121():60-67. PubMed ID: 30616029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in Children with Chronic Disease.
    Högler W; Ward L
    Endocr Dev; 2015; 28():176-195. PubMed ID: 26138842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence.
    Ward LM
    Front Endocrinol (Lausanne); 2023; 14():1266986. PubMed ID: 38374961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.